Phillip Eichorn MD

Dr Eichorn did his medical training in the US and practiced general adult medicine in the outpatient and hospital settings for 10 years before joining the pharmaceutical industry. He joined Pfizer (UK) in 2002 and since then has served a number of roles in the safety, risk management and regulatory documentation functions, including provision of cross-portfolio guidance on the RMP. Much of his current work focuses on partnering with commercial and other non-safety colleagues to promote the quality of AE reports resulting from patient support programs, market research and other activities that involve communication between the company and HCPs, patients and consumers.